MARY-VIRGINIA PARKER: Open Payments
NPI 1952936668 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 84 payments from 25 companies in 2025. Trend: 2023 $569 · 2024 $1,704 · 2025 $1,714
Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $234 |
| Ascendis Pharma Endocrinology Inc | 7 | $167 |
| Amgen Inc. | 7 | $136 |
| Corcept Therapeutics | 5 | $123 |
| SANOFI-AVENTIS U.S. LLC | 5 | $121 |
| Lilly USA, LLC | 7 | $121 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| Sequel Med Tech, LLC | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
Products named: MINIMED 780G, Yorvipath, Korlym, TZIELD, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, EVENITY, TWIIST.
Industry payments across UT — which companies pay providers there.
